EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudie

Celecoxib has less aggravating effect on cisplatin-induced nephrotoxicity in comparison with non-selective cyclooxygenase inhibitors: a retrospective multi-institutional study

Keisuke Okamoto, Yoshitaka Saito, Kenta Takahashi, Yoh Takekuma, Jun Sakakibara-Konishi, Katsuya Narumi, Mitsuru Sugawara, Masaki Kobayashi

International Journal of Clinical Oncology · 2025

DOI: 10.1007/s10147-025-02810-5 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Journal of Clinical Oncology, 2025. Verfasst von Keisuke Okamoto und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Sciences, Laboratory of Clinical Pharmaceutics and Therapeutics, Division of Pharmasciences, Hokkaido University, Kita-12-J…. Hauptthemen laut MEDLINE: Celecoxib, Cisplatin, Lung Neoplasms, Cyclooxygenase Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CelecoxibCisplatinLung NeoplasmsCyclooxygenase InhibitorsKidney DiseasesHumansMaleFemaleRetrospective StudiesMiddle AgedAgedNaproxenPhenylpropionatesAdultAntineoplastic Agents

Stichwörter der Autor:innen

CelecoxibCisplatinInduced nephrotoxicityLoxoprofenNaproxenNon-selective cyclooxygenase inhibitorsNon-steroidal anti-inflammatory drugs

Substanzen

CelecoxibCisplatinCyclooxygenase InhibitorsNaproxenPhenylpropionatesloxoprofenAntineoplastic Agents

Autor:innen und Institutionen

  • Faculty of Pharmaceutical Sciences, Laboratory of Clinical Pharmaceutics and Therapeutics, Division of Pharmasciences, Hokkaido University, Kita-12-Jo, Nishi-6-Chome, Kita-Ku, Sapporo, 060-0812, Japan.
  • Faculty of Pharmaceutical Sciences, Department of Clinical Pharmaceutics and Therapeutics, Hokkaido University of Science, 4-1, Maeda 7-Jo 15-Chome, Teine-Ku, Sapporo, 006-8585, Japan. yossypma@med.hokudai.ac.jp.
  • Department of Pharmacy, NTT Medical Center Sapporo, Minami 1-Jo, Nishi 15-Chome, Chuo-Ku, Sapporo, 060-0061, Japan.
  • Department of Pharmacy, Hokkaido University Hospital, Kita-14-Jo, Nishi-5-Chome, Kita-Ku, Sapporo, 060-8648, Japan.
  • Faculty of Medicine, Department of Respiratory Medicine, Hokkaido University, Kita 15-Jo, Nishi 7-Chome, Kita-Ku, Sapporo, 060-8638, Japan.
  • Faculty of Pharmaceutical Sciences, Education Research Center for Clinical Pharmacy, Hokkaido University, Kita-12-Jo, Nishi-6-Chome, Kita-Ku, Sapporo, 060-0812, Japan.

Zitieren

APA

Okamoto, K., Saito, Y., Takahashi, K., Takekuma, Y., Sakakibara-Konishi, J., Narumi, K., Sugawara, M., & Kobayashi, M. (2025). Celecoxib has less aggravating effect on cisplatin-induced nephrotoxicity in comparison with non-selective cyclooxygenase inhibitors: a retrospective multi-institutional study. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-025-02810-5

Vancouver

Okamoto K, Saito Y, Takahashi K, Takekuma Y, Sakakibara-Konishi J, Narumi K, et al. Celecoxib has less aggravating effect on cisplatin-induced nephrotoxicity in comparison with non-selective cyclooxygenase inhibitors: a retrospective multi-institutional study. International Journal of Clinical Oncology. 2025. doi:10.1007/s10147-025-02810-5

BibTeX
@article{Okamoto2025,
  author = {Okamoto, Keisuke and Saito, Yoshitaka and Takahashi, Kenta and Takekuma, Yoh and Sakakibara-Konishi, Jun and Narumi, Katsuya and Sugawara, Mitsuru and Kobayashi, Masaki},
  title = {Celecoxib has less aggravating effect on cisplatin-induced nephrotoxicity in comparison with non-selective cyclooxygenase inhibitors: a retrospective multi-institutional study},
  journal = {International Journal of Clinical Oncology},
  year = {2025},
  doi = {10.1007/s10147-025-02810-5}
}
Kostenlos starten →